Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)
Part of paid clinical trials in Pasadena, California.
- Sponsor
- Huntington Memorial Hospital
- Study ID
- NCT05131594
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Many people who have had COVID 19 continue to experience symptoms long after they have recovered from the acute infection. This study will examine the clinical symptoms of people with "Long COVID" and measure various markers of inflammation in their blood.
Key Dates
- Start date
- Oct 13, 2021
- Status verified
- Sep 2024
- Primary completion
- Jun 30, 2025
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Correlation of symptomatology with inflammatory profiles in patients with Post-Acute Sequelae of SARS-CoV2 (PASC) [ Time Frame: From onset of infection to 24 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Huntington Hospital | Pasadena | California | 91105 | - |
Find similar trials in Pasadena, CA
By condition
By specialty
By research site
Related Studies
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT StudyPHASE3 · Recruiting · Ansun Biopharma, Inc. · Duarte, California
- Impact of the Coronavirus (COVID-19) on Patients With CancerRecruiting · Stanford University · Stanford, California
- A Study to Explore the Role of Gut Flora in COVID-19 InfectionRecruiting · ProgenaBiome · Ventura, California
- Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)Recruiting · Children's Hospital of Orange County · Orange, California